UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.194

Sortiert nach

The secrets of a successful clinical trial: compliance, compliance, and compliance

Molecular interventions, 2011-04, Vol.11 (2), p.107-110

2011

Link zum Volltext

Verfügbarkeit prüfen

Regulation of BDNF expression in primary neuron culture by LY392098, a novel AMPA receptor potentiator

Neuropharmacology, 2001-06, Vol.40 (8), p.1019-1027

2001

Link zum Volltext

Verfügbarkeit prüfen

Selective anxiolysis produced by ocinaplon, a GABA(A) receptor modulator

Proceedings of the National Academy of Sciences - PNAS, 2005-05, Vol.102 (20), p.7380-7385

2005

Link zum Volltext

Verfügbarkeit prüfen

Modulation of glutamate receptors: strategies for the development of novel antidepressants

Amino acids, 2002-01, Vol.23 (1-3), p.153-159

Skolnick, P

2002

Link zum Volltext

Verfügbarkeit prüfen

“Broad spectrum” antidepressants: Is more better for the treatment of depression?

Life sciences (1973), 2003-11, Vol.73 (25), p.3175-3179

2003

Link zum Volltext

Verfügbarkeit prüfen

Antidepressants for the new millennium

European Journal of Pharmacology, 1999-06, Vol.375 (1), p.31-40

Skolnick, Phil

1999

Link zum Volltext

Verfügbarkeit prüfen

Adaptation of N-Methyl-D-Aspartate (NMDA) Receptors following Antidepressant Treatment: Implications for the Pharmacotherapy of Depression

Pharmacopsychiatry, 1996, Vol.29 (1), p.23-26

1996

Link zum Volltext

Verfügbarkeit prüfen

Glutamate and depression: clinical and preclinical studies

Annals of the New York Academy of Sciences, 2003-11, Vol.1003 (1), p.250-272

2003

Link zum Volltext

Verfügbarkeit prüfen

Adaptation of the N-methyl-D-aspartate receptor complex following chronic antidepressant treatments

The Journal of pharmacology and experimental therapeutics, 1994-04, Vol.269 (1), p.95

1994

Link zum Volltext

Verfügbarkeit prüfen

P.2.c.003 A placebo-controlled study of EB-1010, a novel triple re-uptake inhibitor, in patients with major depressive disorder

European neuropsychopharmacology, 2011, Vol.21, p.S384-S385

2011

Link zum Volltext

Verfügbarkeit prüfen

(2S,4R)-4-methylglutamic acid (SYM 2081): a selective, high-affinity ligand for kainate receptors

The Journal of pharmacology and experimental therapeutics, 1997-01, Vol.280 (1), p.422

1997

Link zum Volltext

Verfügbarkeit prüfen

Adaptive changes in the N-methyl-D-aspartate receptor complex after chronic treatment with imipramine and 1-aminocyclopropanecarboxylic acid

The Journal of pharmacology and experimental therapeutics, 1993-06, Vol.265 (3), p.1380

1993

Link zum Volltext

Verfügbarkeit prüfen

Addiction Therapeutics: Obstacles and Opportunities

Biological psychiatry (1969), 2012-12, Vol.72 (11), p.890-891

2012

Link zum Volltext

Verfügbarkeit prüfen

Ethanol Stimulates γ -aminobutyric Acid Receptor-Mediated Chloride Transport in Rat Brain Synaptoneurosomes

Proceedings of the National Academy of Sciences - PNAS, 1986-06, Vol.83 (11), p.4071-4075

1986

Link zum Volltext

Verfügbarkeit prüfen

NMDA antagonist properties of the putative antiaddictive drug, ibogaine

The Journal of pharmacology and experimental therapeutics, 1995-11, Vol.275 (2), p.753

1995

Link zum Volltext

Verfügbarkeit prüfen

Aminoglycoside neurotoxicity involves NMDA receptor activation

Brain research, 1999-01, Vol.815 (2), p.270-277

1999

Link zum Volltext

Verfügbarkeit prüfen

Polyamine-like actions of aminoglycosides at recombinant N-methyl-D-aspartate receptors

The Journal of pharmacology and experimental therapeutics, 1999-10, Vol.291 (1), p.285

1999

Link zum Volltext

Verfügbarkeit prüfen

Therapeutic doses of buspirone block D3 receptors in the living primate brain

The international journal of neuropsychopharmacology, 2014-08, Vol.17 (8), p.1257-1267

2014

Link zum Volltext

Verfügbarkeit prüfen

Putative Partial Agonist 1-Aminocyclopropanecarboxylic Acid Acts Concurrently as a Glycine-Site Agonist and a Glutamate-Site Antagonist at N-Methyl-d-aspartate Receptors

Molecular pharmacology, 1999-12, Vol.56 (6), p.1207-1218

1999

Link zum Volltext

Verfügbarkeit prüfen

Intra- and interstrain differences in models of “behavioral despair”

Pharmacology, biochemistry and behavior, 2001-10, Vol.70 (2), p.187-192

2001

Link zum Volltext

Verfügbarkeit prüfen

Antidepressant-like actions of DOV 21,947: a “triple” reuptake inhibitor

European journal of pharmacology, 2003-02, Vol.461 (2), p.99-104

2003

Link zum Volltext

Verfügbarkeit prüfen

Glycine(B) receptor antagonists and partial agonists prevent memory deficits in inhibitory avoidance learning

Neurobiology of learning and memory, 2000-09, Vol.74 (2), p.146-160

2000

Link zum Volltext

Verfügbarkeit prüfen

Stable expression of type I gamma-aminobutyric acidA/benzodiazepine receptors in a transfected cell line

Molecular pharmacology, 1992-12, Vol.42 (6), p.996-1003

1992

Link zum Volltext

Verfügbarkeit prüfen

Selective anxiolysis produced by ocinaplon, a GABAA receptor modulator

Proceedings of the National Academy of Sciences - PNAS, 2005-05, Vol.102 (20), p.7380-7385

2005

Link zum Volltext

Verfügbarkeit prüfen

Antidepressant-like actions of an AMPA receptor potentiator (LY392098)

Neuropharmacology, 2001-06, Vol.40 (8), p.1028-1033

2001

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 1.194

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.023)
Mit Volltextzugriff
(1.046)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(1.183)
Japanisch
(147)
Französisch
(3)
Russisch
(3)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

The secrets of a successful clinical trial: compliance, compliance, and compliance

Regulation of BDNF expression in primary neuron culture by LY392098, a novel AMPA receptor potentiator

Selective anxiolysis produced by ocinaplon, a GABA(A) receptor modulator

Modulation of glutamate receptors: strategies for the development of novel antidepressants

“Broad spectrum” antidepressants: Is more better for the treatment of depression?

Antidepressants for the new millennium

Adaptation of N-Methyl-D-Aspartate (NMDA) Receptors following Antidepressant Treatment: Implications for the Pharmacotherapy of Depression

Glutamate and depression: clinical and preclinical studies

Adaptation of the N-methyl-D-aspartate receptor complex following chronic antidepressant treatments

P.2.c.003 A placebo-controlled study of EB-1010, a novel triple re-uptake inhibitor, in patients with major depressive disorder

(2S,4R)-4-methylglutamic acid (SYM 2081): a selective, high-affinity ligand for kainate receptors

Adaptive changes in the N-methyl-D-aspartate receptor complex after chronic treatment with imipramine and 1-aminocyclopropanecarboxylic acid

Addiction Therapeutics: Obstacles and Opportunities

Ethanol Stimulates γ -aminobutyric Acid Receptor-Mediated Chloride Transport in Rat Brain Synaptoneurosomes

NMDA antagonist properties of the putative antiaddictive drug, ibogaine

Aminoglycoside neurotoxicity involves NMDA receptor activation

Polyamine-like actions of aminoglycosides at recombinant N-methyl-D-aspartate receptors

Therapeutic doses of buspirone block D3 receptors in the living primate brain

Putative Partial Agonist 1-Aminocyclopropanecarboxylic Acid Acts Concurrently as a Glycine-Site Agonist and a Glutamate-Site Antagonist at N-Methyl-d-aspartate Receptors

Intra- and interstrain differences in models of “behavioral despair”

Antidepressant-like actions of DOV 21,947: a “triple” reuptake inhibitor

Glycine(B) receptor antagonists and partial agonists prevent memory deficits in inhibitory avoidance learning

Stable expression of type I gamma-aminobutyric acidA/benzodiazepine receptors in a transfected cell line

Selective anxiolysis produced by ocinaplon, a GABAA receptor modulator

Antidepressant-like actions of an AMPA receptor potentiator (LY392098)

Suchergebnisse filtern